SP-102

DRUG3 trials

Sponsors

Scilex Pharmaceuticals, Inc., Semnur Pharmaceuticals, Inc.

Conditions

Lumbosacral Radicular Pain

Phase 2

A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102

CompletedNCT03613662

Semnur Pharmaceuticals, Inc.Lumbosacral Radicular Pain

Start: 2018-07-13End: 2019-03-15Updated: 2022-01-13

Phase 3

Corticosteroid Lumbar Epidural Analgesia for Radiculopathy

CompletedNCT03372161

Scilex Pharmaceuticals, Inc.Lumbosacral Radicular Pain

Start: 2017-12-08End: 2022-01-06Updated: 2022-09-19

Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2

Not yet recruitingNCT07579351

Semnur Pharmaceuticals, Inc.Lumbosacral Radicular Pain

Start: 2026-08-01End: 2029-01-01Target: 755Updated: 2026-05-12

Related Papers

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Pain2024-06-145 citations

Repeat Epidural Injections of SP-102 (Dexamethasone Sodium Phosphate Injectable Gel) in Subjects with Lumbosacral Radiculopathy

Journal of Pain Research2021-05-014 citations